Eisai; Pfizer Inc

20.07.2011 – 13:39
New Study Shows Evidence of Lower Rate of Hippocampal Shrinkage in Alzheimer?s Disease Patients Treated With Aricept(R)
London (ots/PRNewswire) - Eisai Europe Ltd and Pfizer Limited today announced the results from a new study conducted in France demonstrating Aricept(R) (donepezil hydrochloride) 10mg significantly reduced the rate of hippocampal atrophy (reduction in volume) in patients with an amnestic syndrome at an early phase of ...
plus
13.07.2009 – 08:09
Majority of Physicians,(1) Alzheimer's Disease (AD) Carers(1) and the General Public(1) in Five European Countries Understand the Need to Detect and Treat AD Early, Yet the Disease Remains Significantly Under-Diagnosed(2)
Vienna (ots/PRNewswire) - - Attitudinal and Behavioural Barriers(1) - Combined with Inability to Recognize Disease Symptoms(1) - Contribute to Delay in Diagnosis and Treatment A new study presented today at a major International medical meeting reveals that approximately two-thirds of physicians in ...
plus